Technology | July 21, 2011

New Release of Elekta's Monaco Treatment Planning System Prepares Software for Stereotactic Radiation Therapy

July 21, 2011 – Among the many new features of Monaco 3.0, dynamic conformal arc (DCA) therapy provides clinicians with a simple way to deliver highly conformal stereotactic plans by using the multi-leaf collimator (MLC) to dynamically conform around a target as the treatment beam rotates around the patient. DCA recently received 510(k) clearance for Monaco from the U.S. Food and Drug Administration (FDA).

"DCA can be used to render more conformal plans by creating multiple arcs in a non-coplanar fashion – in such a way that the geometry of each arc minimizes the dose to the adjacent organs during the gantry rotation," says Todd Powell, executive vice president, Elekta Software. "When this technique is used in conjunction with micro-MLCs – such as the new Apex MLC [not yet available in the United States], which is now supported in Monaco 3.0 – it can yield very conformal plans and is much easier in terms of quality assurance measurements."

DCA is particularly well-suited for stereotactic treatments because it eliminates the need to modulate the typically higher doses per fraction in stereotactic therapy. DCA's benefit, therefore, is fewer monitor units and reduced treatment time compared with other delivery methods.

"With DCA, clinicians have the option to obtain a comparably conformal plan with approximately half the treatment time and reduced scatter dose," Powell adds.

Streamlining the stereotactic workflow is a major goal of Monaco 3.0, which includes:

         -Apex micro-MLC: 2.5 mm nominal leaf resolution, 12 x 14 cm field size

         -Planning with multiple isocenters: Enables same-fraction, single-plan stereotactic treatment of, e.g., multiple brain mets, multiple brain lesions

        -Plan review and summation for any number of plans

        -Summed dose from multiple plans can be saved into a single plan

        -Sensitivity analysis data table integrated into prescription

        -Workflow-enhancing changes to graphical user interface

        -New dose analysis tools

For more information: www.elekta.com

 

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beam will ablate for a noninvasive pulmonary vein isolation procedure. Varian acquires, buys, purchases Cyberheart.

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation procedure to treat an arrhythmia.

Feature | Radiation Therapy | May 10, 2019
May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has deve